New vaccine design uses immunity against influenza to offer faster protection against emerging pathogens
Strategy developed by UC Riverside-led research team speeds up production of antibodies against COVID-19
Partnership between UCR and City of Hope aims to increase diversity in cancer research
$13.7M grant from National Cancer Institute will support several projects on breast and pancreatic cancers
Study reports discovery of new cell type in thymus
UC Riverside biomedical scientists say the cells are like M cells in the gut and airways
Are we right to be frightened of brain worms?
Has the news about an Australian woman with a living, wriggling roundworm in her brain got you spooked? After experiencing abdominal pain and night sweats that developed into forgetfulness and depression, the 64-year-old woman was sent to a hospital. An MRI scan did reveal something unusual in her brain, but...
Could exposure to chemicals in plastics predispose you and your children to cardiovascular disease?
Exposure to environmental chemicals, including those in common plastic products, has been linked with an increased risk of cardiovascular disease, or CVD, the leading cause of death worldwide. According to the World Health Organization , 17.9 million people died from CVDs in 2019. Changcheng Zhou , a professor of biomedical...
Protein found to protect females against obesity
UC Riverside mouse study describes mechanisms underlying sex differences for obesity
UC Riverside-led study sheds light on how IBD can develop
Inflammatory bowel disease, or IBD , describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues. Its symptoms...
Health impact of chemicals in plastics is handed down two generations
UC Riverside mouse study finds paternal exposure to phthalates increases risk of metabolic diseases in progeny
Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus
Study provides insights into fighting broad range of pathogen’s viral strains
UC Riverside experts discuss disease symptoms, vaccines, and anxiety management
COVID-19 vaccines for very young children
UC Riverside vaccine expert David Lo shares his thoughts in a Q&A
UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
Should you get a second booster shot for COVID-19?
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
A potential antiviral for SARS and SARS-like coronaviruses
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
Building robust collaborations to ‘ATTACK’ future pandemics
As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...
A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1